Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India

The Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services, has forecasted a cooperative agreement opportunity titled "Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India." This Notice of Funding Opportunity (NOFO), referenced as CDC-RFA-JG-26-0142, is designed to bolster India’s efforts in eliminating HIV and tuberculosis (TB) as public health threats by strengthening national programs and enabling systemic, sustainable health responses. The grant is part of the CDC’s global health mission, particularly aligning with the goals of the Global AIDS and Tuberculosis programs under Assistance Listings 93.067 and 93.494. The purpose of this funding opportunity is to support India’s National AIDS Control Organization (NACO), Central Tuberculosis Division (CTD), and the Ministry of Health and Family Welfare (MoHFW) by enhancing their capabilities to control and eventually eliminate the spread of HIV and TB. The strategic focus includes transitioning essential public health services to local ownership, building cooperation across government and civil society, and scaling up innovative, evidence-based interventions to prevent new infections, ensure early case detection, promote treatment adherence, and achieve viral suppression. Grant-supported activities will include addressing testing and treatment gaps for HIV and TB, delivering integrated services that address co-morbidities, and improving overall disease surveillance and responsiveness. These interventions aim to reinforce India’s National AIDS Control Program (NACP-VI) and the National TB Elimination Program (NTEP), while aligning with U.S. global health priorities focused on epidemic control and health security. By fostering a locally driven, innovative health infrastructure, the program intends to build a foundation for long-term epidemic control and public health resilience. Although no official award ceiling or floor is listed in the forecast notice, the CDC has indicated that the approximate total fiscal year funding anticipated for Year 1 is $6 million, contingent on the availability of funds. This indicates significant investment in foundational capacity-building and program sustainability over multiple years. Cost-sharing or matching is not required for applicants, which may encourage a broad and diverse pool of organizations to apply. The application process will be entirely electronic and the forecasted due date for submissions is June 12, 2026, at 11:59 PM Eastern Time. The estimated date of award and project start are both scheduled for September 30, 2026. There is no indication of pre-application requirements such as Letters of Intent or concept papers. Evaluation criteria are not explicitly stated in the forecast notice but are expected to focus on organizational capability, alignment with program goals, and proposed methodologies for HIV and TB control. Eligibility for this funding opportunity is broad and includes state and local governments, tribal organizations, nonprofits (with or without 501(c)(3) status), higher education institutions (public and private), for-profit organizations (including small businesses), and public housing authorities, among others. This expansive eligibility framework underscores the CDC’s intent to foster comprehensive and inclusive partnerships across sectors. Interested applicants can direct inquiries to the program email at [email protected]. A direct PDF version of the full NOFO is not yet available as this is a forecasted opportunity.